News
Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Regulatory Round-up - October 2022Cell and Gene Therapy Catapult at Advanced Therapies Integrates: A Bird’s Eye BlogCharles River Laboratories opens cutting-edge cell and gene therapy manufacturing facility at Alderley ParkCGT Catapult named as a Finalist in the British Recruitment Awards 2022London Laboratory and GMP Manufacturing Roundtable White PaperRegulatory Round-up - September 2022Potential to accelerate development in ATMP space demonstrated by ATTC Network partnerCell & Gene Therapy Catapult at Advanced Therapies Europe 2022: A Bird’s Eye BlogAchieve commercial success: the value of a sound manufacturing strategyPress Release: Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform to enable cell therapy commercialisationPress release: CGT Catapult begins Virtual Reality training to help ensure future workforce needsRegulatory Round-up - August 2022
